Enhanced ROS production by NADPH oxidase is correlated to changes in antioxidant enzyme activity in human heart failure

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 3, 2010, Pages 331-338

  Borchi, Elisabetta ^a   Bargelli, Valentina ^a   Stillitano, Francesca ^a   Giordano, Carla ^b   Sebastiani, Mariangela ^b   Nassi, Paolo Antonio ^a   d'Amati, Giulia ^b   Cerbai, Elisabetta ^a   Nediani, Chiara ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Catalase; Glutathione peroxidase; Heart failure; Mn superoxide dismutase; NADPH oxidase

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TYROSINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SYNTHESIS; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HUMAN; HUMAN TISSUE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING;

ADULT; ANTIOXIDANTS; BLOTTING, WESTERN; CATALASE; FEMALE; GLUTATHIONE PEROXIDASE; HEART FAILURE; HEART VENTRICLES; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; NADPH OXIDASE; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 74849093101     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2009.10.014     Document Type: Article

References (39)

1. Byrne J.A., Grieve D.J., Cave A.C., and Shah A.M. Oxidative stress and heart failure. Arch. Mal. Coeur Vaiss. 96 (2003) 214-221
2. Giordano F.J. Oxygen, oxidative stress, hypoxia, and heart failure. J. Clin. Invest. 115 (2005) 500-508
3. Heymes C., Bendall J.K., Ratajczak P., Cave A.C., Samuel J.L., Hasenfuss G., and Shah A.M. Increased myocardial NADPH oxidase activity in human heart failure. J. Am. Coll. Cardiol. 41 (2003) 2164-2171
4. Li J.M., Gall N.P., Grieve D.J., Chen M., and Shah A.M. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 40 (2002) 477-484
5. Dieterich S., Bieligk U., Beulich K., Hasenfuss G., and Prestle J. Gene expression of antioxidative enzymes in the human heart. Circulation 101 (2000) 33-39
6. Hill F.M., and Singal P.K. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am. J. Pathol. 148 (1996) 291-300
7. Akki A., Zhang M., Murdoch C., Brewer A., and Shah A.M. NADPH oxidase signaling and cardiac myocyte function. J. Mol. Cell. Cardiol. 47 (2009) 15-22
8. Dworakowski R., Anilkumar N., Zhang M., and Shah A.M. Redox signalling involving NADPH oxidase-derived reactive oxygen species. Biochem. Soc. Trans. (2006) 34
9. Murdoch C., Zhang M., Cave A., and Shah A. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc. Res. 71 (2006) 208-215
10. Nediani C., Borchi E., Giordano C., Baruzzo S., Ponziani V., Sebastiani M., Nassi P., Mugelli A., d'Amati G., and Cerbai E. NADPH Oxidase-dependent redox signaling in human heart failure: relationship between the left and right ventricle. J. Mol. Cell. Cardiol. 42 (2007) 826-834
11. Baumer A.T., Flesch M., Wang X., Shen Q., Feuerstein Z.G., and Bohm M. Antioxidative enzymes in human hearts with idiopatic dilated cardiomyopathy. J. Mol. Cell. Cardiol. 32 (2000) 121-133
12. Sam F., Kerstetter D., Pimental D., Mulukutla S., Tabaee A., Bristow M., Colucci W., and Sawyer D. Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J. Card. Fail. 11 (2005) 473-480
13. Brieke A., and DeNofrio D. Right ventricular dysfunction in chronic dilated cardiomyopathy and heart failure. Coron. Artery Dis. 16 (2005) 5-11
14. Haddad F., Hunt S.A., Rosenthal D.N., and Murphy D.J. Right ventricular function in cardiovascular disease: Part I. anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 117 (2008) 1436-1448
15. Voelkel N., Quaife R., Leinwand L., Barst R., McGoon M., Meldrum D., Dupuis J., Long C., Rubin L., Smart F., Suzuki Y., Gladwin M., Denholm E., and Gail D. National Heart, Lung and Blood Institute Working Group on cellular and molecular mechanisms of right heart failure, right ventricular function and failure. Report of a National Heart, Lung and Blood Institute Working Group on cellular and molecular mechanisms of right heart failure. Circulation 114 (2006) 1883-1891
16. Hill F.M., and Singal P.K. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 96 (1997) 2414-2420
17. Liu L., Marcocci L., Wong C., Park A., and Suzuki Y. Serotonin-mediated protein carbonylation in the right heart. Free Rad. Biol. Med. 45 (2008) 847-854
18. Modesti P., Vanni S., Bertolozzi I., Cecioni I., Lumachi C., Perna A., Boddi M., and Gensini G. Different growth factor activation in the right and left ventricles in experimental volume overload. Hypertension 43 (2004) 101-108
19. Dang N., Topkara V., Mercando M., Kay J., Kruger K.H., Aboodi M.S., Oz M.C., and Naka Y. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J. Heart Lung Transplant. 25 (2006) 1-6
20. Barbone A., Holmes J., Heerdt P., The' A., Naka Y., Joshi N., Daines M., Marks A.R., Oz M.C., and Burkhoff D. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Circulation 104 (2001) 670-675
21. Klotz S., Barbone A., Reiken S., Holmes J., Naka Y., Oz M.C., Marks A.R., and Burkhoff D. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. J. Am. Coll. Cardiol. 45 (2005) 668-676
22. Puwanant S., Hamilton K., Klodell C., Hill J., Schofield R., Cleeton T., Pauly D., and Aranda J. Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation. J. Heart Lung Transplant. 27 (2008) 1102-1107
23. Sebastiani M., Giordano C., Nediani C., Travaglini C., Borchi E., Zani M., Feccia M., Mancini M., Petrozza V., Cossarizza A., Gallo P., Taylor R., and d'Amati G. Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies. J. Am. Coll. Cardiol. 50 (2007) 1362-1369
24. Aebi H. Catalase in vitro. Methods Enzymol. 105 (1984) 121-126
25. 2: regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-traslational modification. Antioxid. Redox Signal. 7 (2005) 619-626
26. Bedard K., and Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87 (2007) 245-313
27. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol 4 (2004) 181-189
28. Fiorillo C., Nediani C., Ponziani V., Giannini L., Celli A., Nassi N., Formigli L., Perna A.M., and Nassi P.A. Cardiac volume overload rapidly induces oxidative stress-mediated myocyte apoptosis and hypertrophy. Biochim. Biophys, Acta 1741 (2005) 173-182
29. Li J.M., Fan L.M., Christie M.R., and Shah A.M. Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4. Mol. Cell. Biol. 25 (2005) 2320-2330
30. Li J.M., and Shah A.M. Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47 phox subunit. J. Biol. Chem. 278 (2003) 12094-12100
31. Xiao L., Pimentel D., Wang J., Singh K., Colucci W., and Sawyer D. Role of reactive oxygen species and NAD(P)H oxidase in alpha 1-adrenoceptor signaling in adult rat cardiac myocytes. Am. J. Physiol. Cell. Physiol. 282 (2002) C926-C934
32. Gupte R., Vijay V., Marks B., Levine R., Sabbah H., Wolin M., Recchia F., and Gupte S. Upregulation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase activity increases oxidative stress in failing human heart. J. Card. Fail. 13 (2007) 497-506
33. Maack C., Kartes T., Kilter H., Schafers H., Nickenig G., Bohm M., and Laufs U. Oxygen free radical release in human failing myocardium is associated with increased activity of Rac1-GTPase and represents a target for statin treatment. Circulation 108 (2003) 1567-1574
34. Qin F., Patel R., Yan C., and Liu W. NADPH oxidase is involved in angiotensin II-induced apoptosis in H9c2 cardiac muscle cells: effect of apocynin. Free Rad. Biol. Med. 40 (2006) 236-246
35. Seshiah P., Weber D., Rocic P., Valppu L., Taniyama Y., Griendling K., and Angiotensin I.I. stimulation of NAD(P)H oxidase activity upstream mediators. Circ. Res. 91 (2002) 406-413
36. Borchi E., Parri M., Papucci L., Becatti M., Nassi N., Nassi P., and Nediani C. Role of NADPH oxidase in H9c2 cardiac muscle cells exposed to simulated ischemia-reperfusion. J. Cell. Mol. Med. (2008) Electronic publication ahead of print
37. Folden D., Gupta A., Sharma A., Li S., Saari J., and Ren J. Malondialdehyde inhibits cardiac contractile function in ventricular myocytes via a p38 mitogen-activated protein kinase-dependent mechanism. Br. J. Pharmacol. 139 (2003) 1310-1316
38. Cao C., Leng Y., Huang W., Liu X., and Kufe D. Glutathione peroxidase 1 is regulated by the c-Abl and Arg tyrosine kinases. J. Biol. Chem. 278 (2003) 39609-39614
39. Cao C., Leng Y., and Kufe D. Catalase activity is regulated by c-Abl and Arg in the oxidative stress response. J. Biol. Chem. 278 (2003) 29667-29675